Evaluation of the measurement of lysate homocysteine in patients with symptomatic arterial disease and in healthy volunteers.

References 1. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963–6. 2. Holvoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998;137(Suppl):S33–8. 3. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408–16. 4. Daugherty A, Roselaar SE. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc Res 1995;29: 297–311. 5. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67–75. 6. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of lowdensity lipoproteins. Methods Enzymol 1994;233:425–41. 7. McDowell IFW, McEneny J, Trimble ER. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995;32:167–74. 8. McEneny J, Trimble ER, Young IS. A simple method for assessing coppermediated oxidation of very-low-density-lipoprotein isolated by rapid ultracentrifugation. Ann Clin Biochem 1998;35:504–14. 9. Brussaard HE, Gevers Leuven JA, Kluft C, Krans HMJ, van Duyvenvoorde W, Buytenhek R, et al. Effect of 17b-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler Thromb Vasc Biol 1997;17:324–30. 10. Scheek LM, Wiseman SA, Tijburg LBM, van Tol A. Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases susceptibility to oxidation in vitro. Atherosclerosis 1995;117:139–44. 11. Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H. Factors affecting resistance of low density lipoproteins to oxidation. Lipids 1996;31:S7-1– S7-6. 12. Kleinveld, HA, Hak-Lemmers HLK, Stalenhoef AFH, Demacker PNM. Improved measurement of low-density-lipoprotein susceptibility to copperinduced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066–72. 13. Lefevre G, Mayara I, Peynet J, Couderc R, GERBAP Section Lipoprotéines. Effect of sucrose/280 °C storage of plasma on between-site values of low-density lipoprotein susceptibility to copper-induced oxidation. Clin Chim Acta 1997;258:249–55. 14. Princen HMG, Duyvenvoorde WV, Buytenhek R, Blonk C, Tijburg LBM, Langius JAE, et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998;18:833–41. 15. Princen HMG, Van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not b-carotene in vivo protects low density lipoprotein form lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb 1992;12:554–62. 16. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Gevers Leuven JA, van Hinsbergh VWM. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995;15:325–33. 17. Gross MD, Prouty CB, Jacobs DR Jr. Stability of carotenoids and a-tocopherol during blood collection and processing procedures. Clin Chem 1995; 41:943–4. 18. Van de Vijver LPL, Kardinaal AFM, van Duyvenvoorde W, Kruijssen DACM, Grobbee DE, van Poppel G, Princen HMG. LDL oxidation and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18:193–9.